Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 3330

Journal of Biotechnology & Biomaterials received 3330 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

Feasibility of investing time and money in genetic engineering: Commercials perspective

2nd World Congress on Bio Summit & Molecular Biology Expo

Saif Aldeen Saleh Al Ryalat

The University of Jordan, Jordan

ScientificTracks Abstracts: J Biotechnol Biomater

DOI: 10.4172/2155-952X.C1.061

Abstract
As we previously stated in our first speech, the emerging technologies (e.g., CRISPR-Cas9) provided an opportunity to every scientist with innovative view to achieve his goal with minimal money and time. To get an overview about the importance of genetic research, 2 examples will be discussed in details in this regard; the highest cited article in NATURE is a genetic study entitled â??An integrated encyclopedia of DNA elements in the human genomeâ? that has more than 4200 citations in the past 4 years. The other example is what professors Gerngross and Hutchinson achieved in the years 2000 to 2006; they genetically modified the yeast Pichia pastoris to produce functional erythropoietin. In 2006, Merck offered 400 million in cash to buy their innovative invention and keep them on the head of their project but huge funding. With the emerging technologies that ease the genetic engineering, it is worth to think of an investment in this field, there are many similar examples where simple lab with few innovative scientists turned into â??money factoryâ?.
Biography

Saif Aldeen Saleh Al Ryalat is a leading Researcher in several aspects of medicine, including genetic engineering and neurology. He is working on a project to design a bio-production system to design aglycosylated antibodies that can replace monoclonal glycosylated antibodies that are used in several neurological diseases (relatively high cost). He is also a peer Reviewer for several journals and a Researcher with several high impact publications. He is currently working at School of Medicine at The University of Jordan where he had several honors and certificates.

Email: saifryalat@yahoo.com

Top